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Mycobacterium tuberculosis 
Rv3160c is a TetR‑like 
transcriptional repressor 
that regulates expression 
of the putative oxygenase Rv3161c
Hasan Tükenmez1,2,3,4*, Souvik Sarkar1,3, Saber Anoosheh1,3, Anastasiia Kruchanova2,3, 
Isabel Edström2,3, Gregory A. Harrison5, Christina L. Stallings5, Fredrik Almqvist1,3 & 
Christer Larsson2,3,6*
Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is a major health threat listed among the 
top 10 causes of death worldwide. Treatment of multidrug‑resistant Mtb requires use of additional 
second‑line drugs that prolong the treatment process and result in higher death rates. Our team 
previously identified a 2‑pyridone molecule (C10) that blocks tolerance to the first‑line drug isoniazid 
at C10 concentrations that do not inhibit bacterial growth. Here, we discovered that the genes rv3160c 
and rv3161c are highly induced by C10, which led us to investigate them as potential targets. We show 
that Rv3160c acts as a TetR‑like transcriptional repressor binding to a palindromic sequence located 
in the rv3161c promoter. We also demonstrate that C10 interacts with Rv3160c, inhibiting its binding 
to DNA. We deleted the rv3161c gene, coding for a putative oxygenase, to investigate its role in drug 
and stress sensitivity as well as C10 activity. This Δrv3161c strain was more tolerant to isoniazid and 
lysozyme than wild type Mtb. However, this tolerance could still be blocked by C10, suggesting that 
C10 functions independently of Rv3161c to influence isoniazid and lysozyme sensitivity.
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is still a major infectious disease  worldwide1. 
In 2018, an estimated 10 million people fell ill with TB and 1.5 million died  globally1. The fight against TB is 
exacerbated by the emergence of multidrug-resistant strains (MDR-TB) resistant to at least two of the first-line 
drugs to treat TB, isoniazid (INH) and  rifampicin1. These infections require additional second-line drugs and 
longer duration of treatment where the treatment success rate drops  substantially1. Over the last 50 years, only 
three new TB drugs have been developed and approved for use against TB: bedaquiline, delamanid and most 
recently, pretomanid. However, there are already several cases reported with TB resistant to both bedaquiline 
and  delamanid2–5. Therefore, there is still a desperate need to develop new strategies to target drug-resistant Mtb.
Previously, our team described a thiazolo ring-fused 2-pyridone (C10) with the ability to increase sensitivity 
to oxidative stress, acid stress and the first-line antibiotic  INH6. C10 was found to potentiate the bactericidal 
activity of INH and prevent the occurrence of INH-resistant  mutants6. Moreover, INH-resistant katG mutants 
were re-sensitized to INH in the presence of C10, demonstrating that INH resistance can be  circumvented6. We 
also showed that C10 inhibited respiration in Mtb, and previous reports have shown that both inhibition and 
stimulation of Mtb respiration can potentiate bactericidal activity of  INH7,8. However, the link between C10 
effects on respiration and C10 effects on INH sensitivity were not elucidated. The C10 target(s) in Mtb as well as 
molecular mechanism of the INH potentiation is unknown.
Here, we discovered the rv3160c-rv3161c operon to be induced by C10 in Mtb. We found that C10 inhibits 
DNA-binding activity of Rv3160c, a putative TetR-like transcription factor, and results in increased expression 
of Rv3161c, a protein of unknown function related to oxygenases found in other bacteria. When knocked out, 
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Δrv3161c mutants became more tolerant to both INH and lysozyme, indicating that the Rv3161c plays an active 
role in both INH potentiation and maintenance of cell wall integrity. However, the Δrv3161c mutants can still 
be sensitized to both INH and lysozyme by C10, excluding the potential involvement of rv3160c-rv3161c in the 
C10 effect.
Results
Expression of the rv3160c‑rv3161c operon is upregulated in response to C10. In our previous 
study, the small molecule C10 was discovered to reduce tolerance to oxidative stress, acid stress and to the first 
line antibiotic INH in Mtb6. Furthermore, C10 could restore INH sensitivity in otherwise INH-resistant katG 
 mutants6. C10 also perturbed respiratory homeostasis, but its mechanism of action is  unclear6.
In order to identify the target(s) of C10 and discover the mechanism behind its INH potentiation, we re-
visited our previous RNA-seq data and looked closer at the top genes induced by C10. The rv3160c and rv3161c 
genes, positioned within a proposed two-gene  operon9,10, were among the top 5 genes upregulated by C10 under 
hypoxic growth conditions (13-fold and 12-fold, respectively)6. These genes particularly caught our attention, 
as they have been shown to be induced by triclosan, an antibacterial that inhibits InhA, resulting in deficient 
mycolic acid synthesis in Mtb, similar to  INH11,12.
According to the RNA-seq results, upregulation of the rv3160c-rv3161c operon by C10 was observed under 
hypoxic growth conditions but not under aerated conditions. To investigate this further, we performed quantita-
tive real-time PCR (qRT-PCR) analysis of the rv3160c-rv3161c operon in response to C10 molecule under aerobic 
conditions. To improve solubility of C10, we used a C10-imidazole salt (C10-IMD) instead of C10 during this 
study (Fig. S1)6. qRT-PCR data showed that expression of the rv3160c-rv3161c operon increases 102 ± 32-fold 
under aerated growth conditions upon exposure to 25 µM C10-IMD for 48 h (Fig. 1). Furthermore, expression 
of this operon was induced even further, 1035 ± 571-fold upon exposure to a combination of 25 µM C10-IMD 
and 0.1 µg/ml INH for 48 h (Fig. 1). There were no significant changes in expression of the operon upon exposure 
to either 0.1 µg/ml INH or 25 µM IMD alone for 48 h (Fig. 1). These findings suggest that INH and C10-IMD 
have a synergistic role in the induction of the rv3160c-rv3161c operon. Based on this, we decided to investigate 
the rv3160c-rv3161c operon further.
Rv3160c is a TetR‑like transcription repressor of the rv3160c‑rv3161c operon. The rv3160c gene 
encodes a putative TetR family transcriptional regulator (TFTR) and is uniquely found in mycobacteria causing 
 TB13. Mycobacterial genomes are highly enriched with several TFTRs, of which the majority act as repressors of 
gene  expression13. Even though Rv3160c has been suggested to be a TFTR based on sequence domain similari-
ties to other TFTRs, its function and possible target(s) have not been described. The majority of the TetR-like 
transcriptional repressors are known to regulate their neighboring genes and often to be co-transcribed with 
their regulatory  targets13. Several previous studies have suggested that the rv3160c and the rv3161c genes are 
located within the same operon based on their correlated gene expression in response to various environmental 
 factors11,14–19. However, a genome wide study suggested the rv3160c gene to have its own independent transcrip-
Expression of the rv3160c-rv3161c operon















































Figure 1.  Expression of the rv3160c-rv3161c operon is significantly induced by C10-IMD. Mtb Erdman WT 
was cultivated in Sauton’s medium at 37 °C until its  OD600 reached 0.3. The cells were then exposed to 0.1% 
DMSO, 0.1 µg/ml INH and 25 µM C10-IMD separately or in combination for 48 h at 37 °C. Differences in 
expression of the rv3160c-rv3161c operon were determined by qRT-PCR analysis performed by targeting 
rv3161c coding region. Expression of the sigA gene was determined by qRT-PCR analysis and used as 
housekeeping control. Relative fold-change in rv3160c-rv3161c operon expression was calculated for each 
biological replicate by the Livak  (2−ΔΔCt) method. Bar graphs were plotted based on average and standard 
deviation obtained from three independent biological replicates and statistical analysis comparing to the DMSO 
control was determined by one-tail t-test that was performed using GraphPad Prism version 8.4.3 for Windows, 
GraphPad Software, San Diego, California USA, www.graph pad.com (**p < 0.01).
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tional start site (TSS) starting at 406 bp upstream of the rv3160c open reading frame (ORF), overlapping with 
the rv3161c  ORF20. To determine which promoter region was responsible for the transcription of rv3160c in 
our conditions, we measured the expression levels of the rv3160c gene while targeting the region between the 
rv3160c-rv3161c operon TSS and the recently proposed independent TSS of the rv3160c gene with a CRISPRi 
construct (Fig. S2). We found that the expression of the rv3160c gene was significantly reduced suggesting that 
rv3160c is mainly co-transcribed with the rv3161c gene (Fig. S2). However, the existence of additional TSSs, 
perhaps of importance in response to other conditions, cannot be excluded based on this data.
We designed an experiment to test whether expression of the neighboring rv3161c gene was regulated by 
Rv3160c (Fig. 2A). We reduced expression of rv3160c gene (~ threefold) by rv3160c-CRISPRi (Fig. 2B), which 
resulted in a 33 ± 3-fold increased expression of the rv3161c gene (Fig. 2C). This data shows that decreasing 
rv3160c expression results in an increase in rv3161c expression, although it does not show whether this occurs 
through direct regulation or not.
TFTRs typically bind to palindromic motifs as dimers, thus we searched for such motifs in the upstream 
sequence of the rv3160c-rv3161c operon. We identified a stretch of 50 bp containing 12-bp and 8-bp inverted 
repeats starting at the − 29 bp upstream of the operon (Fig. 3A). We confirmed that Rv3160c binds to a 142 bp 
DNA fragment containing these palindromic motifs, resulting in a DNA shift using the electrophoretic mobil-
ity shift assay (EMSA) (Fig. S3). We then digested the 142 bp DNA fragment with different restriction enzymes 
to narrow down the region that is targeted by Rv3160c (Fig. S3). We found that that presence of both inverted 
repeats as well as the − 10 region were necessary for an efficient interaction, thus we decided to use 86 bp DNA 
fragment containing both these palindromic motifs for the remaining EMSAs (Fig. 3B). The binding of Rv3160c 
to these palindromes would block access of the RNAP to the − 10 sigma factor binding site and repress transcrip-
tion of the rv3161c. To test if the palindromic motifs were important for Rv3160c binding, we performed EMSAs 
with modified DNA fragments. We used a higher concentration of Rv3160c (100 pmol) in these assays compared 
to those presented in Fig. 3 (10 pmol) to ensure the protein was in excess to detect lower affinity binding events. 






































































































Figure 2.  Rv3160c acts as transcriptional repressor of the rv3160c-rv3161c operon. (A) Schematic 
representation of the rv3160c-rv3161c operon and the relative positions of the targets for CRISPRi and qRT-
PCR. (B,C) qRT-PCR analysis of rv3160c and rv3161c mRNA expression in Mtb Erdman WT strain harboring 
either vector control (pJR965) or the rv3160c-CRISPRi (pSA253) construct in absence (−) or presence (+) of 
100 ng/ml aTc. sigA mRNA expression was used as control and relative fold change in rv3160c and rv3161c 
mRNA expression were calculated for each biological replicate by the Livak  (2−ΔΔCt) method. Average value 
of 3 technical replicates was used for each biological replicate. Bar graphs were plotted based on average and 
standard deviation obtained from three independent biological replicates and statistical analysis was determined 
by one-tail t-test that was performed using GraphPad Prism version 8.4.3 for Windows, GraphPad Software, San 
Diego, California USA, www.graph pad.com (*p < 0.05, **p < 0.01).
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Figure 3.  Binding of Rv3160c to the rv3160c-rv3161c operon is blocked by C10-IMD. (A) Schematic depicting 
model of the Rv3160c dimer binding to the palindromic sequence present in the rv3161c upstream fragment. 
(B) EMSA assay using an 86 bp rv3161c upstream fragment (1 pmol; lanes 1–3) and a 204 bp cfp10 upstream 
fragment as negative control fragment (1 pmol; lanes 4–5). Lane 1 and 5: no protein added. Lanes 2, 3 and 5: 
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DNA band. Nevertheless, this interaction would not interfere with the migration of the band in the acrylamide 
gels as staining took place after the gel runs were completed. We evaluated Rv3160c binding by quantifying the 
amount of unbound DNA in the presence of Rv3160c as a percentage of the unbound DNA in the absence of 
Rv3160c for each DNA construct. To test if the inner palindrome is important for Rv3160c binding, we shuf-
fled the 8 bp inverted repeats in the inner palindrome, without eliminating the palindrome structure or base 
composition (Fig. S5A). Rv3160c showed decreased binding to the fragment harboring a shuffled inner palin-
drome, leaving 83% of the DNA unbound, as compared to the unmodified fragment, where only 8% of the DNA 
remains unbound by Rv3160c (Fig. S5B). We then incubated Rv3160c with DNA fragments harboring a shuffled 
outer palindrome or harboring both shuffled inner and outer palindromes and found that nearly all of the DNA 
remained unbound in the presence of Rv3160c (Fig. S5). Furthermore, by modifying the two non-matching 
nucleotides located between the inner and outer palindromes to create a single 21 bp inverted repeat, we found 
that Rv3160c was still able to bind most of the DNA fragment, leaving 37% of the DNA unbound (Fig. S5A). 
These findings demonstrate that the ability of Rv3160c to bind the sequence upstream of rv3161c is dependent 
on the sequence of both inverted repeats.
C10‑IMD inhibits the interaction between Rv3160c and the rv3161c upstream target 
sequence. As mentioned above, expression of the rv3160c-rv3161c operon is induced by C10-IMD. Thus, 
we hypothesized that C10-IMD might interfere with Rv3160c function. Indeed, we found that Rv3160c was 
no longer capable of interacting with the sequence upstream of rv3161c in the presence of C10-IMD in the 
EMSA (Fig. 3B). To investigate whether C10-IMD interacted directly with Rv3160c, we analyzed the effect of 
C10-IMD on Rv3160c tryptophan fluorescence emission. There are 3 tryptophan residues available in Rv3160c 
and the binding interaction between C10-IMD and Rv3160c was studied using tryptophan fluorescence. The 
presumption is that if C10-IMD binds Rv3160c and some of the tryptophan residues are in close proximity to 
the C10-IMD binding site, compound binding might affect the intrinsic fluorescence of Rv3160c. Rv3160c was 
titrated with increasing concentrations of C10-IMD and relative fluorescence intensity was found to decrease in 
a concentration-dependent manner (Fig. 4A). The fluorescence quenching was further analyzed by Stern–Vol-
mer equation (Eq. 1, see “Methods” section) to determine the Stern–Volmer quenching constant  (Ksv) (Fig. 4B), 
which signifies the equilibrium binding constant for complex formation in the light-induced electronic excited 
state resulting in the quenching of intrinsic fluorescence of tryptophan. In this study, the Stern–Volmer plot 
analyzes the type of fluorescence quenching of tryptophan residues in Rv3160c by plotting relative emission 
intensity against C10-IMD concentration. In the case of Rv3160c, a tryptophan might be buried in the protein, 
whose fluorescence quenching depends on the microenvironment, solvent accessibility, and binding of C10-
IMD. Overall, the tryptophan fluorescence quenching is a combined contribution of the microenvironment of 
all tryptophan residues in the presence of C10-IMD. If tryptophan residues are in close proximity of C10-IMD 
binding site, C10-IMD binding leads to fluorescence quenching of tryptophan while the fluorescence of other 
tryptophan residues that are not involved in C10-IMD binding would not be quenched. The Stern–Volmer plot, 
therefore, helps to understand the binding process leading to quenching  phenomena21. To calculate the binding 
dissociation constant  (KD) and the number of binding site (n), the logarithmic Eq. (2) (see “Methods” section) 
was used. The log(Kb)  (Kb denotes binding association constant) value had been determined from the intercept 
of the plot, shown in Fig. 4C. The binding dissociation constant  (KD) was found to be 44.51 ± 0.85 µM using 
Eq. (3). The number of binding sites for the C10-IMD in Rv3160c was found to be 0.94 ± 0.09 suggesting one 
binding site of C10-IMD in Rv3160c.
TFTRs usually consist of two domains: one signal-receiving and the other one DNA-binding. Interactions 
of TFTRs with their target DNAs often lead to structural changes, especially in the DNA-binding  domain22–25. 
Similarly, specific molecules can bind to the regulatory domain of TFTRs, resulting in conformational changes 
that make TFTRs incapable of binding their DNA  targets26,27. According to our EMSA experiments, Rv3160c 
cannot bind to its DNA target upon addition of C10-IMD. Thus, we investigated whether interaction with C10-
IMD results in conformational changes in Rv3160c using circular dichroism (CD) spectroscopy. We discovered 
that the ellipticity of Rv3160c was reduced upon addition of its DNA target, indicating changes in the secondary 
structure (Fig. 4D). In contrast, no change in the ellipticity of Rv3160c was observed in the presence of C10-IMD 
(Fig. 4E), indicating that C10-IMD did not alter the secondary structure of Rv3160c in the absence of DNA. 
There is a slight change in the ellipticity in the presence of C10-IMD approximately at 208 nm in Fig. 4E does 
not have much impact on overall secondary structure of Rv3160c.
Deletion of rv3161c results in increased sensitivity to INH and lysozyme. C10-IMD directly 
binds Rv3160c, a TetR-like transcriptional repressor, which could be leading to the increased expression of the 
rv3160c-rv3161c operon in the presence of C10-IMD. We hypothesized that INH potentiation by C10-IMD 
might be regulated through the cellular concentration of Rv3161c, a putative oxygenase. To test this, we used 
recombineering to generate a rv3161c knock-out strain and tested its sensitivity to INH. Both wild type and 
Δrv3161c strains were incubated for 2 weeks at 37 °C with varying concentrations of INH in U-bottomed 96-well 
plates. After 2-weeks incubation, we scored the pellet formations in each well as a semi-quantitative indication 
of bacterial growth and spotted them on 7H10 plates followed by additional 3-weeks of incubation at 37  °C 
to assess the presence of viable bacteria. We discovered that the Δrv3161c strain was more resistant to INH in 
comparison to wild type, as it could survive up to double the INH concentration (0.016 µg/ml) (Fig. 5). We also 
observed that addition of 5 µM C10-IMD potentiated INH sensitivity in both wild type and Δrv3161c strains, 
demonstrating that the effect of C10-IMD on INH potentiation occurs independently of Rv3161c (Fig. 5).
Previous studies show that expression of the rv3160c-rv3161c operon is upregulated in the lipid-rich 
 environments18 and upon treatment with cell wall synthesis  inhibitors11,17,19, raising the question of whether 
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these genes play a role in cell wall integrity. We set up a similar growth and survival assay to test the cell wall 
integrity of both wild type and Δrv3161c strains by incubating them in the presence of varying concentrations 
of lysozyme, an antimicrobial enzyme that cleaves the peptidoglycan component of the bacterial cell wall. The 
Δrv3161c strain survived exposure up to double the lysozyme concentration (62.5 µg/ml) compared to the wild 
type strain (Fig. 5). In addition, we found that both the wild type and Δrv3161c strains were more sensitive to 
lysozyme in the presence of 5 µM C10-IMD (Fig. 5).
Discussion
Expression of the rv3160c-rv3161c operon has been reported to be induced by various anti-microbial agents 
such as  triclosan11,19,  thioridazine16,17,19, SRI#96715, SRI#919015 and  chlorpromazine19. Rv3161c encodes a puta-
tive oxygenase that shares high amino acid sequence identity (32–62%) with other Rieske oxygenases found in 
several organisms. Rieske oxygenases are known to be involved in the degradation of arenes, therefore it has 
been suggested that Rv3161c might hydroxylate the benzene ring structures found in these anti-microbial agents 
resulting in  detoxification11,15,17. However, neither deletion nor overexpression of the rv3161c gene influenced the 
minimal inhibitory concentration (MIC) of triclosan or other anti-microbial  agents28. Therefore, upregulation 
of rv3161c expression was suggested to be a failed attempt of the bacteria to counteract these  drugs28. In another 
study, mutations in the rv3161c gene were found to cause resistance against the 2,4-diaminoquinazoline (DAQ) 
A)
B) Ksv = (1.97 ± 0.001) x 104 M-1 C) KD = 44.51 ± 0.85 μM
n   = 0.94 ± 0.09
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E)















     No DNA
  1 µM DNA
10 µM DNA















       No C10-IMD




























































    1











Figure 4.  C10-IMD binds to a single site in Rv3160c and the interaction does not cause changes in the 
secondary structure of the protein. (A) Fluorescence quenching spectra of Rv3160c. The 10 µM Rv3160c in PBS 
solution is excited and quenching of fluorescence is recorded in the presence of varying concentrations of C10-
IMD (1–100 μM). (B) Stern–Volmer plot of decrease in mean fluorescence intensity of Rv3160c in the presence 
of varying concentrations of C10-IMD derived from three independent experiments. The dynamic quenching 
rate constant  Ksv is evaluated from the slope of the line. (C) Logarithmic plot of mean relative fluorescence 
quenching of Rv3160c derived from three independent experiments against logarithmic concentrations of 
C10-IMD.  KD is calculated from the intersection of the line with the y axis and the number of binding sites (n) 
from the slope of the line. (D) CD spectra of Rv3160c in the presence of 1 µM or 10 µM 86 bp rv3161c upstream 
fragment (DNA) (Fig. 2C). (E) CD spectra of Rv3160c in the presence of 10 µM or 100 µM C10-IMD. Error bars 
in (B) and (C) indicate standard deviation.
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anti-tubercular agent and Rv3161c was proposed to convert pro-drug DAQ into its active  form29. Despite all of 
these previous studies, the mechanism of action of the Rv3161c in response to antimicrobial agents is still unclear.
We discovered that rv3161c is highly expressed in response to the C10-IMD compound that previously 
has been shown to potentiate INH  sensitivity6. Induced rv3161c expression was also observed as a response to 
2-aminoimidazoles (2-AI), a class of molecules that potentiate sensitivity to β-lactam antibiotics by increas-
ing cell  permeability14. Several studies have suggested that Rv3161c is involved in lipid metabolism and cell 
wall  biogenesis11,17–19. In this study, we found that Δrv3161c mutants become more resistant to INH as well 
as lysozyme, an enzyme degrading the peptidoglycan layer of the cell wall (Fig. 5). We hypothesize that ele-
vated Rv3161c may disturb the cell wall integrity and increase cell permeability, resulting in increased INH and 
lysozyme sensitivity. The Δrv3161c mutants can still be sensitized against both INH and lysozyme by C10-IMD, 
demonstrating that C10-IMD functions independent of Rv3161c to elicit these effects (Fig. 5). We tried to gen-
erate a Δrv3160c mutant to test whether elevated Rv3161c in the absence of C10-IMD could increase sensitivity 
against INH and lysozyme, however we failed to generate such a mutant in several attempts.
In this study, we clarified the function of Rv3160c as a TetR-like transcriptional repressor that regulates 
rv3161c expression. Despite the fact that several publications have suggested the rv3160c-rv3161c operon to 
be involved in key processes such as drug detoxification, lipid metabolism and cell wall  biogenesis11,14–19,29, the 
function of the Rv3161c remains unknown. Further investigation aiming to elucidate the function of Rv3161c 
will lead to important insights into Mtb biology.
Methods
Bacterial strains and growth conditions. WT E. coli DH5α was grown in Luria Broth (Difco) as shak-
ing cultures at 37 °C and kanamycin at 50 µg/ml was used for selection when required.
WT Mtb Erdman and the rv3161c knockout with Mtb Erdman background were grown in either Middle-
brook 7H9 medium (BD Difco) supplemented with 0.05–0.1% Tween80 and 10% ADS (0.5% albumin, 0.2% 
dextrose and 0.085% saline) or Sauton’s medium [0.0005% (w/v)  KH2PO4, 0.0005% (w/v)  MgSO4, 0.004% (w/v) 
l-asparagine, 0.06% glycerol, 0.00005% (w/v) ferric ammonium citrate, 0.002% (w/v) citric acid, 0.0001%  ZnSO4, 
pH 7] supplemented with 0.1% Tween80 as liquid shaking cultures at 37 °C. These strains were also grown on 
Middlebrook 7H10 solid medium (Remel) supplemented with 0.05% Tween80, 0.2–0.5% Glycerol and 10% ADS 
at 37 °C. Kanamycin at 20 µg/ml and anhydrotetracycline (aTc) at 100 ng/ml were used when required. All the 























































Figure 5.  Deletion of the rv3161c gene results in higher resistance to isoniazid and lysozyme. (A) 
Representative images showing effect of INH and lysozyme on bacterial growth scored by pellet formation. Mtb 
Erdman WT and ∆rv3161c strains were incubated 2 weeks in Sauton’s medium with 0.02% DMSO or 5 µM 
C10-IMD in addition to various concentration of INH (left; 0.002–0.064 µg/ml) or lysozyme (right; 3.9–125 µg/
ml). (B) Representative images showing effect of INH and lysozyme treatment on bacterial survival scored by 
spotting bacteria exposed to INH (left; 0.002–0.064 µg/ml) or lysozyme (right; 3.9–125 µg/ml) in the presence of 
0.02% DMSO or 5 µM C10-IMD on antibiotic-free 7H10 plates.
8
Vol:.(1234567890)
Scientific Reports |         (2021) 11:1523  | https://doi.org/10.1038/s41598-021-81104-y
www.nature.com/scientificreports/
Construction of rv3160c‑CRISPRi and rv3161c‑CRISPRi strains. To investigate regulation of the 
rv3160c-rv3161c operon, we silenced expression of the rv3160c and the rv3161c genes individually by using the 
 dCas9Sth1 CRISPRi  system30. This system utilizes a catalytically inactivated CRISPR1 cas9 allele and provides an 
RNA-guided platform for sequence-specific control of gene expression. The single guide RNAs (sgRNAs) for 
each gene were determined and ranked by PAM score. Forward and reverse oligonucleotides (Table S2) cor-
responding to the top-ranked sgRNA sequence for each gene were annealed together to form double stranded 
DNA fragments and subsequently cloned into the BsmBI site of pLJR965 as described  before30. The resulting 
plasmids, named pSA253 (targeting rv3160c) and pSA256 (targeting rv3161c), were electroporated into Mtb 
Erdman to obtain TB3 and TB4 respectively.
RNA isolation and cDNA synthesis. Mtb Erdman strains harboring pLRT965 (empty vector), pSA253 
(targeting rv3160c) or pSA256 (targeting rv3161c) were grown in 7H9 medium supplemented with 0.05% 
Tween80, 10% ADS and 20 µg/ml kanamycin until their optical density  (OD600) reaches to 0.3 in the presence of 
aTc (100 ng/ml) to induce expression of gene-specific sgRNA. Same strains were also cultivated similarly but in 
the absence of aTc as non-induced controls. Equivalents of 6  OD600-unit cells were harvested by centrifugation 
and resuspended in 1 ml TRI Reagent (Invitrogen). Cell suspensions were transferred into screw-cap homog-
enizing tubes containing 0.4 ml of 0.1 mm Zirconia/Silica beads (BioSpec) and lysed in a bead beater 8 times for 
30 s with a 1-min rest on ice between each cycle. After a centrifugation at 13,000 g for 45 s, supernatants were 
transferred into new tubes and mixed with 300 µl chloroform followed by incubation at room temperature for 
2 min. The samples were centrifuged at 13,000 g for 5 min and aqueous phase were transferred into new tubes. 
An equal volume of absolute ethanol was mixed with each sample and subsequently transferred into RNeasy col-
umns (Qiagen) followed by purification according to the manufacturer’s instruction. Isolated RNA samples were 
then DNase-treated with TURBO DNA-free kit (Invitrogen) to eliminate any genomic DNA contamination. 
cDNA was prepared using qScript cDNA Synthesis kit (Quantabio) according to the manufacturer’s instruction.
Quantitative real‑time PCR. Expression levels of rv3160c and rv3161c genes were determined by qRT-
PCR with cDNA equivalent to 50 ng RNA using Maxima SYBR Green/ROX qPCR Master Mix (Thermo Scien-
tific) and the oligonucleotides listed in Table S3. RNA samples that were not reverse transcribed were used to 
confirm that there were no DNA contamination, and the integrity of the amplicons were confirmed by melting 
curves for each sample. All qRT-PCR experiments were performed with three technical replicates derived from 
three biological replicates. Signals were normalized to the housekeeping sigA mRNA and quantified by the Livak 
 (2−ΔΔCt)  method31. The Ct values of induced samples were compared to the corresponding Ct values of unin-
duced samples. Statistical analysis was performed using the one-tailed t-test and the results were plotted as bar 
graphs based on average and standard deviation obtained from three biological replicates by GraphPad Prism 
version 8.4.3 for Windows, GraphPad Software, San Diego, California USA, www.graph pad.com.
Electrophoretic mobility shift assay. EMSA was performed with 142 bp rv3161c upstream fragment 
(undigested or digested with BglI, HincII or TaqI), 86 bp rv3161c upstream fragment (wild type or altered) or 
204 bp cfp10 upstream fragment. The 142 bp rv3161c upstream sequence was directly amplified from chromo-
somal DNA with BS3161F and BS3161R oligonucleotides. Complementary oligonucleotides bearing the 86 bp 
rv3161c upstream sequence (wild type or altered) were annealed and amplified with UniPal_F and UniPal_R 
oligonucleotides (Table S4). cfp10 upstream sequence was also directly amplified from chromosomal DNA with 
EMSA_CFP10-F and EMSA_CFP10-R oligonucleotides (Table  S4). The binding reactions were prepared in 
10 mM Tris–HCl (pH 8.0), 150 mM KCl, 0.5 mM EDTA (pH 8.0), 0.1% Triton-X 100, 12.5% glycerol, 0.2 mM 
DTT, 0.1 mg/ml BSA and 10 ng/ul Poly-dIdC in the presence of 1 or 4 pmol DNA targets, 10 or 56 pmol Rv3160c 
(produced by the Protein Expertise Platform at Umeå University in 1× PBS) and/or 50 nmol C10-IMD and 
incubated for 30 min at 37 °C. Reaction mixes were then loaded onto 6% polyacrylamide gels and run at 80 V 
in 0.5% TBE buffer for 75 min. The gels were then stained in 3× GelRed (Biotium) buffer for 15 min followed by 
washing with MQ water for 15 min twice. The DNA was visualized with UV-transilluminator and signals were 
analyzed by Image J Software version 1.52a32.
Fluorescence spectroscopy. The interaction between C10-IMD and Rv3160c was analyzed by concen-
tration-dependent response of C10-IMD on Rv3160c tryptophan fluorescence emission measured in Hitachi 
F-4500 fluorescence spectrophotometer. Rv3160c emission spectra were acquired using 10 μM of protein dis-
solved in 1× PBS (pH 6.8) with or without adding C10-IMD and was incubated for 1 min at 37 °C in a quartz 
cuvette. The resulting solution was excited at 290 nm for tryptophan residue and the intrinsic fluorescence emis-
sion was scanned from 300 to 460 nm. The data from each read was then combined and plotted using the Spec-
tragryph Software version 1.2.1333. The fluorescence quenching data have been corrected for inner filter effects. 
Fluorescence quenching was determined by analyzing the data by the classical Stern–Volmer equation:
where  Fo and F are the fluorescence intensities in the absence and presence of the quencher, respectively.  Kq is the 
bimolecular quenching rate constant and  Ksv is the dynamic quenching constant. Average lifetime of the protein 
in absence of the quencher is expressed in terms of τo whereas [Q] is the concentration of the free quencher. 
When small molecules interact with several comparable sites in a protein, the equilibrium between liberated and 
bound molecules is expressed by the equation:
(1)F0/F = 1+ kqτ0[Q] = 1+ Ksv[Q]
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where  Kb represents binding constant for quencher-protein interaction, n is the number of binding sites per 
molecule of Rv3160c,  KD denotes binding dissociation constant.
Circular dichroism (CD) spectroscopy. CD spectroscopy was performed with Rv3160c as described 
 earlier34. The native secondary structure of Rv3160c was compared using far-UV range CD spectra in presence 
of various concentrations of C10-IMD (10 µM and 100 µM) and 86 bp rv3161c upstream DNA bait (1 µM and 
10 µM). The spectra were recorded using Jasco CD spectrometer at a range of 200 to 260 nm from 10 µM of 
Rv3160c in optically clear buffer under the nitrogen atmosphere at 25 °C. The buffer baseline corrected spectra 
were processed with an average of 5 scans and presented as units of mean residue ellipticity.
Impact of isoniazid and lysozyme on bacterial growth and survival. The bactericidal/bacterio-
static properties of isoniazid and lysozyme were assayed at varying concentrations (0.002–0.064 µg/ml for INH 
or 3.9–125 µg/ml for lysozyme) in Sauton’s medium with 0.02% DMSO or 5 µM C10-IMD for both Mtb Erdman 
wild type and Δrv3161c strains as described in our previous  study35.
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